Omeros | OMER - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Adma Biologics USD 528.2M 17.03M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Cytokinetics USD 1.21B 369.02M 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Immunic USD 188.76M 165.89M 2026-03
Insmed USD 1.63B 20.75M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
MacroGenics USD 321.69M 139.16M 2026-06
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 615.21M 100.25M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Rockwell Medical USD 31.61M 1.42M 2025-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06